Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma
=============================================================================================================================================================================

* Sapna P Patel
* Gina R Petroni
* Jason Roszik
* Walter C Olson
* Nolan A Wages
* Kimberly A Chianese-Bullock
* Mark Smolkin
* Nikole Varhegyi
* Elizabeth Gaughan
* Kelly T Smith
* Kathleen Haden
* Emily H Hall
* Sacha Gnjatic
* Patrick Hwu
* Craig L Slingluff